<DOC>
	<DOCNO>NCT01612260</DOCNO>
	<brief_summary>The purpose study assess effect Chinese medicine Shensong Yangxin capsule chronic cardiac dysfunction complicate ventricular premature beat .</brief_summary>
	<brief_title>Shensong Yangxin Capsule Treatment Heart Failure Complicated With Ventricular Premature Beat</brief_title>
	<detailed_description>Premature ventricular contraction one common arrhythmia patient structural heart disease heart failure , high incidence also high predictive value sudden death . The purpose study assess effect Chinese medicine Shensong Yangxin capsule chronic cardiac dysfunction complicate ventricular premature beat , base number premature ventricular contraction 24-hour ambulatory electrocardiogram ( ECG ) main endpoint study . Secondary endpoint evaluation Shensong Yangxin capsule cardiac function quality life . This study randomize , double-blind , placebo control , multi-center trial . Chronic heart failure patient ( cardiac function Class II-III ) associate premature ventricular contraction ( premature number 720-10000 / 24h ) , receive standardized treatment heart failure least three month , involve study . Patients randomly assign Shensong Yangxin capsule group placebo group , capsule administration 4 granule t.i.d.for 12 week . 24-hour ambulatory ECG , echocardiography evaluation heart function observe baseline 12 week intervention . The primary outcome number premature ventricular contraction 24-hour ambulatory ECG , secondary outcome New York Heart Association ( NYHA ) classification , NT-proBNP , leave ventricular ejection fraction ( LVEF ) leave ventricular end-diastolic dimension ( LVEDD , 6 minute walk test Minnesota live heart failure questionnaire ( MLHFQ ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Ventricular Premature Complexes</mesh_term>
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<criteria>Patients cardiac function NYHA II~III , Left ventricular ejection fraction ( LVEF ) 35 % ~50 % test Modified Simpson , stable hemodynamics need deliver treatment vein To treat standard treatment heart failure least 3 month stable dosage already Ventricular premature beat : 72010000 beats/24 hour Heart failure cause ischemic heart disease , dilate cardiomyopathy Subject expect alive 6 month Subject suffer acute coronary syndrome last three month ( Acute myocardial infarction ST segment elevation non ST segment elevation , unstable angina To complicate persistent atrial fibrillation , atrioventricular conduction block ( II degree Type II III degree ) , acute myocarditis To complicate ventricular fibrillation , torsion type ventricular heartbeat rate , sustain ventricular tachycardia , non sustain ventricular tachycardia rapid ventricular rate hemodynamic disorder Sinus heart rate le 45 beats/minutes need receive pacemaker receive pacemaker , abnormal sinus node function The hypertension , diabetes difficult control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>heart failure</keyword>
	<keyword>ventricular premature complex</keyword>
	<keyword>Shensong Yangxin capsule</keyword>
</DOC>